angiotensin ii has been researched along with indole-3-carbinol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooker, G; Fleming, S; Kantachuvesiri, S; Kotelevtsev, Y; Lammie, AG; McGrath, I; Mullins, JJ; Peters, B; Peters, J | 1 |
| Howard, LL; Mitchell, KD; Mullins, JJ; Patterson, ME | 1 |
| Mitchell, KD; Mullins, JJ | 1 |
| Bagatell, SJ; Miller, CS; Mitchell, KD; Mouton, CR; Mullins, JJ; Seth, DM | 1 |
| Mitchell, KD; Mullins, JJ; Patterson, ME | 1 |
| Bürgelová, M; Cervenka, L; Erbanová, M; Husková, Z; Kramer, HJ; Mullins, JJ; Rakusan, D; Thumová, M; Vanecková, I; Vanourková, Z | 1 |
| Kavanagh, KL; Liu, L; Mitchell, KD; Mullins, JJ; Prieto, MC; Williams, DE | 1 |
| Clemetson, KJ; Gebhard, S; Gesell-Salazar, M; Greinacher, A; Hammer, E; Kuttler, B; Peters, B; Peters, J; Rettig, R; Scharf, C; Steil, L; Völker, U | 1 |
| Graciano, ML; Mitchell, KD | 1 |
| Cervenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Jíchová, S; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Nishiyama, A; Sadowski, J; Sporková, A | 1 |
| Červenka, L; Doleželová, Š; Falck, JR; Husková, Z; Imig, JD; Jíchová, Š; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Neckář, J; Reddy, RN; Sadowski, J; Vernerová, Z | 1 |
11 other study(ies) available for angiotensin ii and indole-3-carbinol
| Article | Year |
|---|---|
Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Precursors; Hypertension; In Situ Hybridization; Indoles; Kidney; Kinetics; Mice; Pedigree; Peptidyl-Dipeptidase A; Precipitin Tests; Promoter Regions, Genetic; Rats; Rats, Inbred Strains; Renin; Time Factors; Transcription, Genetic; Transgenes | 2001 |
Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Cytochrome P-450 CYP1A1; Disease Models, Animal; Glomerular Filtration Rate; Hypertension, Renal; Indoles; Mice; Rats; Renal Circulation; Renin; Sodium Chloride, Dietary | 2005 |
Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Benzimidazoles; Biphenyl Compounds; Cytochrome P-450 CYP1A1; Feedback; Glomerular Filtration Rate; Hypertension, Malignant; Indoles; Kidney Glomerulus; Kidney Tubules; Male; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Renal Circulation; Renin; Tetrazoles | 2005 |
Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Gene Expression; Hypertension; Hypertension, Malignant; Indoles; Kidney; Male; Mice; Promoter Regions, Genetic; Rats; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System | 2006 |
Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Citrulline; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP1A1; Enzyme Inhibitors; Hypertension, Malignant; Indoles; Kidney; Male; Nitric Oxide Synthase Type I; Rats; Regional Blood Flow; Renin; Sulfonamides; Thiourea; Vasoconstriction | 2008 |
Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cytochrome P-450 CYP1A1; Glomerular Filtration Rate; Hemodynamics; Homeostasis; Hypertension; Indoles; Kidney; Losartan; Male; Natriuresis; Rats; Rats, Transgenic; Receptor, Angiotensin, Type 1; Renal Circulation; Renin; Renin-Angiotensin System; Sodium; Time Factors | 2009 |
Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension.
Topics: Angiotensin II; Angiotensinogen; Animals; Cytochrome P-450 CYP1A1; Gene Expression; Hypertension, Malignant; Indoles; Kidney Cortex; Kidney Medulla; Kidney Tubules, Collecting; Male; Prorenin Receptor; Rats; Rats, Transgenic; Receptors, Cell Surface; Renin; Renin-Angiotensin System | 2011 |
Angiotensin II-dependent hypertension causes reversible changes in the platelet proteome.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Genetically Modified; Blood Platelets; Humans; Hypertension; Indoles; Male; Mass Spectrometry; Proteome; Proteomics; Rats; Rats, Inbred F344; Renin; Risk Factors | 2011 |
Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Benzamides; Cytochrome P-450 CYP1A1; Hypertension, Malignant; Imatinib Mesylate; Indoles; Kidney; Male; Piperazines; Pyrimidines; Rats; Rats, Transgenic; Receptors, Platelet-Derived Growth Factor; Renin | 2012 |
Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cytochrome P-450 CYP1A1; Epoxide Hydrolases; Hypertension; Indoles; Kidney; Male; Mice; Natriuresis; Rats; Rats, Inbred F344; Rats, Transgenic; Renin; Renin-Angiotensin System | 2014 |
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Albuminuria; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cytochrome P-450 CYP1A1; Hypertension, Malignant; Indoles; Kidney; Male; Peptide Fragments; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Time Factors | 2016 |